Research Progress on the Relationship between CMI and Obstructive Sleep Apnea-Hypopnea Syndrome

Corresponding author: Yang quan fu, 625348750@qq.com

DOI: 10.12201/bmr.202604.00103

•  

  Abstract: Obstructive sleep apnea-hypopnea syndrome (OSAHS) is a significant factor driving the development of various cardiometabolic diseases (CMDs). Given the complex associations between OSAHS and CMDs such as hypertension and diabetes, developing biomarkers for comprehensively assessing metabolic health and cardiovascular risk is particularly important. The cardiometabolic index (CMI), which integrates parameters such as triglycerides, high-density lipoprotein cholesterol, and waist-to-height ratio, provides a more sensitive and comprehensive tool for evaluating metabolic risk. This review aims to explore the pathophysiological links between CMI and OSAHS, its efficacy as a predictive marker for OSAHS, and its role in risk stratification for OSAHS-related cardiometabolic complications. It seeks to elucidate the clinical significance of CMI in the management of OSAHS, identify the limitations of current research, and outline future research directions, in order to provide new perspectives and theoretical foundations for the early identification, precise intervention, and improved prognosis of OSAHS.

  Key words: Cardiometabolic Index; Obstructive Sleep Apnea-Hypopnea Syndrome; Complication; Research Progress

  Submit time: 13 April 2026

  Copyright: The copyright holder for this preprint is the author/funder, who has granted biomedRxiv a license to display the preprint in perpetuity.
• html

• 图表

• 何飞龙, Liu Qianqian, Liu Yangkun, ChenYunfeng. Progress in research on the comorbidity of interstitial lung disease and obstructive sleep apnea. 2026. doi: 10.12201/bmr.202607.00016

  Jin Xueqin. 4 Barros ÂF, Murta-Nascimento C, Abdon CH, et al. Factors associated with time interval between the onset of symptoms and first medical visit in women with breast cancerJ. Cad Saude Publica, 2020, 36(2): e00011919.. 2025. doi: 10.12201/bmr.202506.00021

  Duan Lingzhi, Yu Yingping, Li Huimin, Wang Xiang, Zhang Aihua. Mechanism of HIF-1 Signaling Pathway in Obstructive Sleep Apnea and Current Research Status of Traditional Chinese Medicine Interventions. 2025. doi: 10.12201/bmr.202512.00021

  Zhenghaijuan, NiuXiaohan. Research Progress of CCR and metabolic syndrome and its related diseases. 2025. doi: 10.12201/bmr.202501.00048

  沈思齐, Wu Luyao, Fang Haoxiang, Shao Yanfei. Mechanism and research progress of flavonoids in prevention and treatment of nephrotic syndrome. 2025. doi: 10.12201/bmr.202511.00086

  CHU Tong, XIAO Xi, WANG Peijuan. Research Progress on the Core Metabolic Pathological Mechanisms and Treatment Strategies of Polycystic Ovary Syndrome. 2025. doi: 10.12201/bmr.202512.00007

  XuHong. Advances in the treatment of osteopenia-seropathic obesity syndrome in the elderly. 2024. doi: 10.12201/bmr.202411.00064

  JIANG Yunlan, LI Le, CHEN Hong, WANG Jing, ZHANG Mengjie, BAI Xiaoyu, WU Senlin. Risk factors for metabolic syndrome in hospitalized schizophrenia patients in China: a Meta-analysis. 2025. doi: 10.12201/bmr.202504.00071

  SHEN Qing. Advances in Novel Pharmacotherapies for Cardiovascular-Kidney-Metabolic Syndrome. 2026. doi: 10.12201/bmr.202604.00070

• ID	Submit time	Number	Download
  1	2026-03-22	10.12201/bmr.202604.00103V1	Download

• Public  Anonymous  To author only Submit Comments